France· FR:64317942
NEXPOVIO 20 mg, comprimé pelliculé
A selinexor product containing sélinexor, registered in France by STEMLINE THERAPEUTICS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Selinexor is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XX66 (selinexor), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Selinexor · ATC L01XX66
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of selinexor costs, country by country.
Normalised to the WHO defined daily dose (18.6 mg), the median price runs from $0.99 in France to $402.73 in Switzerland — a ×406 gap.
- France: $0.99 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Selinexor · price per daily dose (18.6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$402.73
- FR France$0.99
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SÉLINEXOR
- Manufacturer
- STEMLINE THERAPEUTICS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- L01XX66
- ATC class
- Selinexor
- Defined daily dose
- 18.6 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 4
4 priced- cip13340093025800212 comprimés conditionnés en 4 plaquettes PVC polychlortrifluoroéthylène PVC-Aluminium de 3 comprimés suremballées avec fermeture de sécurité enfant lEUR 2.81
- cip13340093025801916 comprimés conditionnés en 4 plaquettes PVC polychlortrifluoroéthylène PVC-Aluminium de 4 comprimés suremballées avec fermeture de sécurité enfantEUR 3.71
- cip13340093025802620 comprimés conditionnés en 4 plaquettes PVC polychlortrifluoroéthylène PVC-Aluminium de 5 comprimés suremballées avec fermeture de sécurité enfantEUR 4.6
- cip13340093025804032 comprimés conditionnés en 4 plaquettes PVC polychlortrifluoroéthylène PVC-Aluminium de 8 comprimés suremballées avec fermeture de sécurité enfantEUR 7.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
72 interactions on record for selinexor.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Selinexor · interactions on record
72 records
- 29 severe
- 43 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Selinexor in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandNexpovio 20 mg, FilmtablettenStemline Therapeutics Switzerland GmbH
- CzechiaNEXPOVIOStemline Therapeutics B.V., Amsterdam
- FinlandNEXPOVIOStemline Therapeutics B.V.
- IrelandNEXPOVIO 20 mg film-coated tabletsKaryopharm Europe GmbH
- IcelandNEXPOVIOStemline Therapeutics B.V.
- NetherlandsNEXPOVIO 20 mg, filmomhulde tabletStemline Therapeutics B.V.
- PolandNEXPOVIOStemline Therapeutics B.V.
- SwedenNEXPOVIO 20 mg Filmdragerad tablettStemline Therapeutics B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nexpovio
- Liechtenstein · Nexpovio
- Norway · Nexpovio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2bd474d-5b80-40f5-880d-602b3b30d1f2 GET /v1/drugs/a2bd474d-5b80-40f5-880d-602b3b30d1f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64317942",
"date_amm": "2021-03-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1537",
"substance": "SÉLINEXOR",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about selinexor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.